There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Rutgers Advances Non-Opioid Solutions for Chronic Pain.
- How Gender Bias Influences Math Education.
- Join NJ ACTS for Special Populations Seminar on 4/28 at 12pm
- Drug Metabolism Group Spring Symposium and Vendor Exhibition on May 5th
- Rutgers Health Begins Clinical Trial to Determine If B1 Can Slow Alzheimer’s Disease.
Categories
- Community (2,477)
- Covid (999)
- CTO Events (6)
- News (3,142)
- Pilots (21)